LWAM
Legacy Wealth Asset Management’s Boston Scientific BSX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.41M | Sell |
22,466
-659
| -3% | -$70.8K | 0.61% | 30 |
|
|
2025
Q1 | $2.33M | Sell |
23,125
-933
| -4% | -$94.1K | 0.64% | 26 |
|
|
2024
Q4 | $2.15M | Sell |
24,058
-450
| -2% | -$40.2K | 0.58% | 33 |
|
|
2024
Q3 | $2.05M | Buy |
24,508
+472
| +2% | +$39.6K | 0.55% | 44 |
|
|
2024
Q2 | $1.85M | Buy |
24,036
+13,303
| +124% | +$1.02M | 0.52% | 44 |
|
|
2024
Q1 | $735K | Hold |
10,733
| – | – | 0.2% | 141 |
|
|
2023
Q4 | $620K | Sell |
10,733
-15
| -0.1% | -$867 | 0.2% | 165 |
|
|
2023
Q3 | $567K | Buy |
10,748
+54
| +0.5% | +$2.85K | 0.21% | 163 |
|
|
2023
Q2 | $578K | Sell |
10,694
-7,051
| -40% | -$381K | 0.2% | 170 |
|
|
2023
Q1 | $888K | Sell |
17,745
-214
| -1% | -$10.7K | 0.32% | 92 |
|
|
2022
Q4 | $831K | Sell |
17,959
-270
| -1% | -$12.5K | 0.32% | 102 |
|
|
2022
Q3 | $706K | Sell |
18,229
-3,441
| -16% | -$133K | 0.31% | 106 |
|
|
2022
Q2 | $808K | Buy |
21,670
+256
| +1% | +$9.55K | 0.33% | 119 |
|
|
2022
Q1 | $948K | Buy |
21,414
+626
| +3% | +$27.7K | 0.34% | 112 |
|
|
2021
Q4 | $883K | Buy |
20,788
+2,183
| +12% | +$92.7K | 0.3% | 130 |
|
|
2021
Q3 | $807K | Buy |
18,605
+28
| +0.2% | +$1.22K | 0.37% | 103 |
|
|
2021
Q2 | $794K | Buy |
18,577
+633
| +4% | +$27.1K | 0.35% | 112 |
|
|
2021
Q1 | $694K | Buy |
17,944
+427
| +2% | +$16.5K | 0.32% | 130 |
|
|
2020
Q4 | $630K | Buy |
+17,517
| New | +$630K | 0.32% | 128 |
|